Teva Pharmaceuticals USA, Inc Amoxicillin and Clavulanate Potassium for Oral recall: Subpotent drug; Clavulanate Potassium component
Subpotent drug; Clavulanate Potassium component
The hazard: Potency, impurity or stability failure
An out-of-specification result prompted this notice — potency, an impurity, or stability over the shelf life.
What the notice says: Subpotent drug; Clavulanate Potassium component
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0151-2026
- Published
- November 12, 2025
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Teva Pharmaceuticals USA, Inc
- Product type
- Prescription & OTC drugs
- Units affected
- 4680 cartons
- Distribution
- California, Mississippi, Ohio
- Made in
- United States
- Lot / code info
- Lot # 100062316, Exp Date: 01/2026
Products covered by this recall
Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
Check your product
The notice names 8 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 100062316
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 01
- 2026 — 4680 cartons
NDC number
On the carton and again on the bottle or blister label.
- 0093-2277-7
Package size
Match the net weight or the piece count on the front of the pack.
- 200 mg
- 28.5 mg
- 5 mL
- 100 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Potency
Teva Pharmaceuticals USA, Inc — An out-of-specification result prompted this notice — potency, an impurity, or stability over the shelf life.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Report any change in how the medicine is working to FDA MedWatch, which is where most of these signals originate.
- Do not stop a prescription on your own. For most conditions an uncertain dose is safer than no dose while you get advice.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: Teva Pharmaceuticals USA, Inc — 400 Interpace Pkwy Bldg A, Parsippany, NJ, 07054-1120
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Teva Pharmaceuticals USA, Inc prescription & otc drugs recalled?
Subpotent drug; Clavulanate Potassium component Subpotent drug; Clavulanate Potassium component
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 100062316; best-by date 01 or 2026 — 4680 cartons. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Which states were affected?
The notice lists California, Mississippi, Ohio.
Related recalls
-
Class II · last month
Teva Pharmaceuticals USA, Inc traZODone Hydrochloride Tablets, USP, 50 mg recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class II · 6 months ago
Teva Pharmaceuticals USA, Inc Octreotide Acetate for Injectable Suspension recall: Lack of Assurance of Sterility: Quality system deficiencies identified during
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
-
Class II · 6 months ago
Teva Pharmaceuticals USA, Inc Claravis , 10 mg, Packaged as a) 100-count carton recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
-
Class II · 6 months ago
Teva Pharmaceuticals USA, Inc Clonidine Transdermal System, USP, 0.2 mg/day recall: CGMP Deviations: use of an unapproved raw material
CGMP Deviations: use of an unapproved raw material
-
Class II · 6 months ago
Teva Pharmaceuticals USA, Inc Clonidine Transdermal System, USP, 0.1 mg/day recall: CGMP Deviations: use of an unapproved raw material
CGMP Deviations: use of an unapproved raw material
-
Class II · 6 months ago
Teva Pharmaceuticals USA, Inc Clonidine Transdermal System, USP, 0.3 mg/day recall: CGMP Deviations: use of an unapproved raw material
CGMP Deviations: use of an unapproved raw material